Services
Expertises
Resources
Who we are
Contact us
Open

Innovation Seed Grant

Seed funding for innovative Angelman syndrome research

Offered by
Foundation for Angelman Syndrome Therapeutics (FAST)
Official source: cureangelman.org

Record updated

Funding available
$ 10,000 - $ 50,000
Deadline
Open continuously
Location
Canada
Who can apply
Individual researchers
See full eligibility

Overview

This program provides seed funding of $10,000 to $50,000 for innovative Angelman syndrome research. It supports proof-of-concept studies, early-stage feasibility work, and high-risk, high-reward projects focused on treatment strategies, therapeutic targets, and biomarker discovery.

At a glance

Funding available

Maximum funding
$50,000
Minimum funding
$10,000
Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Conduct research or evaluation activities

Eligible candidates

Location
  • Canada
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
All groups
Legal structures
Non-profit
Non-profit candidates
Sector of operation
Research
Target groups
People with disabilities, Academia / students
Revenue structures
100% donations / grants
Scope
National

Start applying for this program

Take a practical assessment to gain a clear understanding of how well this program aligns with your specific needs and long-term goals.

Availability timeline

2026
Periods: 1

Eligibility

Who is eligible?

  • Individual researchers
  • Multidisciplinary research teams
  • Academic institutions
  • Industry scientific teams

Who is not eligible

  • Organizations that do not have nonprofit status, except in rare cases specifically allowed by the program

Eligible expenses

  • Reagents and services, including gene chips, chemical libraries, cell lines, and animal model lines
  • Specialized services such as sequencing, proteomics, metabolomics, mass spectrometry, antibody production, and drug or chemical manufacturing
  • Specialized equipment or software for specific projects
  • Personnel salaries and fringe benefits, up to 20% of requested funds

Ineligible Costs and Activities

  • Indirect costs
  • General office supplies and equipment
  • Bridging funds to cover gaps in grant funding

Eligible geographic areas

  • United States

Activities funded

  • Proof-of-concept research on Angelman syndrome
  • Early-stage feasibility studies
  • Research on new treatment strategies
  • Therapeutic target discovery and biomarker identification

How to apply

  • Step 1: Prepare the Letter of Intent
    • Draft the one-page Letter of Intent.
    • Include hypotheses and specific aims.
    • Add a lay summary.
    • Attach the detailed budget and biosketch.
  • Step 2: Submit Online
    • Upload the application materials electronically through the ProposalCentral link.
    • Submit the application on a rolling basis.
  • Step 3: Follow Up if Needed
    • Contact FAST by email with questions about the application process.

Documents Needed

  • Letter of Intent
  • Research hypotheses and specific aims
  • Lay summary
  • Detailed budget
  • Biosketch of the PI and collaborators

Processing and Agreement

  • Applications are reviewed on a rolling basis.
  • Recipients must submit a final written and financial report after the project ends.
  • FAST reviews progress with the Scientific Panel after report submission.
  • Research using human or animal subjects requires the relevant institutional approvals before funds or activities proceed.

Additional information

  • Applications are reviewed on a rolling basis.
  • A final report is required within 60 days after project end.
  • Human subjects research requires IRB approval before funds are released.
  • Animal studies require IACUC approval before animal work begins.

Contacts

science@cureangelman.org

Official sources

Innovation Seed Grant

Program guide

Application ProcessGrant Application Process

Application form

FoundationFoundation for Angelman Syndrome Bi-Yearly Progress Report FormFoundation for Angelman Syndrome Final Report FormLetter of Intent to Foundation for Angelman Syndrome Therapeutics

Supporting document

Carry-Forward RequestGrant Renewal RequestNO-COST Extension Request
Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Innovation Seed Grant Program

What is the Innovation Seed Grant?

This program provides seed funding of $10,000 to $50,000 for innovative Angelman syndrome research. It supports proof-of-concept studies, early-stage feasibility work, and high-risk, high-reward projects focused on treatment strategies, therapeutic targets, and biomarker discovery.

How much funding can be received?

Innovation Seed Grant Funds up to $50,000 of admissible expenses.

What is the deadline to apply?

The program is accepting continuous intake

Who is eligible for the Innovation Seed Grant program?

To be eligible for the Innovation Seed Grant program, you must: Research focused on Angelman syndrome Proof-of-concept or early-stage work Researchers, teams, or collaborations

What expenses are eligible under Innovation Seed Grant?

Reagents and services, including gene chips, chemical libraries, cell lines, and animal model lines Specialized services such as sequencing, proteomics, metabolomics, mass spectrometry, antibody production, and drug or chemical manufacturing Specialized equipment or software for specific projects Personnel salaries and fringe benefits, up to 20% of requested funds

Who can I contact for more information about the Innovation Seed Grant?

You can contact Foundation for Angelman Syndrome Therapeutics (FAST) by email at science@cureangelman.org.

Where is the Innovation Seed Grant available?

The Innovation Seed Grant program is available across Canada.